Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A for infantile esotropia
NL-OMON24276Active, not recruiting
- Sponsor
- Het Oogziekenhuis Rotterdam
- Start
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in Congenital Esotropia (CE), sponsored by Het Oogziekenhuis Rotterdam. Primary endpoint: Proportion of successful motor alignment at six months. Started Dec 2013; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
Congenital Esotropia (CE)
Beyond the preview
Go deeper on NL-OMON24276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24276.